Skip main navigation
×

Dynamic Changes in Long-Term Exposure to Ambient Particulate Matter and Incidence of Hypertension in Adults

A Natural Experiment
Originally publishedhttps://doi.org/10.1161/HYPERTENSIONAHA.119.13212Hypertension. 2019;74:669–677

    Abstract

    Many countries dedicated in mitigation of air pollution in the past several decades. However, little is known about how air quality improvement affects health. Therefore, we conducted current study to investigate dynamic changes in long-term exposure to ambient particulate matter (PM2.5) and incidence of hypertension in a large longitudinal cohort. We recruited 134 978 adults aged 18 years or above between 2001 and 2014. All the participants received a series of standard medical examinations, including measurements of blood pressure. The PM2.5 concentration was estimated using a satellite-based spatiotemporal model at a high resolution (1×1 km2). The change in long-term exposure to PM2.5 (ΔPM2.5) was defined as the difference between the values measured during follow-up and during the immediately preceding visit, and a negative value indicated an improvement in PM2.5 air quality. Time-varying Cox model was used to examine the associations between ΔPM2.5 and the development of hypertension. The results show that PM2.5 concentrations increased in 2002, 2003, and 2004, but began to decrease in 2005. Every 5 µg/m3 change in exposure to PM2.5 (ie, a ΔPM2.5 of 5 µg/m3) was associated with a 16% change in the incidence of hypertension (hazard ratio, 0.84; 95% CI, 0.82–0.86). Both stratified and sensitivity analyses generally yielded similar results. We found that an improvement in PM2.5 exposure is associated with a decreased incidence of hypertension. Our findings demonstrate that air pollution mitigation is an effective strategy to reduce the risk of cardiovascular disease.

    Introduction

    Ambient air pollution, which increases mortality and morbidity and shortens life expectancy, is the leading contributor to disease burden in the world. More than 90% of the global population resides in areas where the air quality does not reach the standards recommended by the World Health Organization.1 It is estimated that fine particulate matter (PM2.5) alone contributed to 105.7 million disability-adjusted life years and 4.1 million deaths worldwide in 2016.2

    Many countries recognize air pollution as a critical risk factor affecting public health and thus have strived to reduce air pollution. Many cities and regions, especially those with advanced economies, have experienced dynamic increases and decreases in air pollution in the past several decades. In contrast to the abundant literature on the adverse effects of air pollution, only a few studies have directly examined the beneficial health effects of improvements in air quality, including decreased mortality,3,4 a longer life expectancy,5 and improvements in lung function growth6 and respiratory symptoms.7,8 However, the linkage between improvements in air quality and the associated beneficial effects is particularly interesting to the field of public health because it would inspire government agencies to adopt more aggressive strategies of air pollution mitigation if the benefits of decreased pollution could be demonstrated.

    Hypertension, a leading risk factor for disability and death worldwide, accounted for >10.5 million deaths in 2016.2 Findings from previous studies suggested that long-term exposure to PM2.5 was associated with an increased risk of hypertension development.9–13 The PM2.5 concentration in Taiwan, which peaked in approximately 2004 and began to decrease thereafter, provides a good backdrop for a natural experiment to examine the beneficial effects of air quality improvement on hypertension. In this analysis, we investigated the relationship between dynamic changes in long-term exposure to ambient PM2.5 (ΔPM2.5) during 2001 to 2014 and incident hypertension in a large longitudinal cohort consisting of 134 978 Taiwanese adults.

    Methods

    The data that support the findings of this study are available from the corresponding author on reasonable request.

    Study Population

    Participants in the current study are from an ongoing longitudinal cohort since 1996. Details have been described in our previous publications.9,14–16 In Brief, more than 0.5 million participants joined a standard medical screening program run by the MJ Health Management Institution between 1994 and 2014. The participants were encouraged to visit the firm periodically through a paid membership and underwent a series of medical examinations during each visit, including anthropometric measurements, physical examinations, and blood and urinary tests. Participants were also asked to complete a self-administered questionnaire to provide information on their lifestyle and medical history. The MJ Health Management Institution has started to computerize the data generated from the medical examinations since 1996. All participants were asked to sign an informed consent before they joined the medical screening program for authorizing the use of their data for research. Ethical approval for this study was obtained from the Joint Chinese University of Hong Kong-New Territories East Cluster Clinical Research Ethics Committee.

    Figure S1 in the online-only Data Supplement shows participant’s selection in this study. A total of 422 013 participants aged 18 years or older were recruited between 2001 and 2014, when PM2.5 exposure assessments were available. Of this population, we excluded 234 765 participants because they had completed only one medical visit. We further excluded 35 203 participants with missing information on height or weight (n=215), lifestyle factors or educational level (n=19 418), systolic or diastolic blood pressure (n=8596), fasting glucose (n=166), or blood lipids (n=6808). Another 17 067 participants with hypertension at their first visit (ie, baseline) were further excluded. The remaining 134 978 participants were included in this analysis to investigate the association between ΔPM2.5 and incident hypertension. Compared with the excluded participants, the included participants were younger (mean: 37.92 versus 40.56 years), more educated (percentage of college/university or above: 68.72% versus 60.22%), less likely to be smokers (percentage of ever-smokers: 24.98% versus 26.82%) or drinkers (percentage of ever-drinkers: 13.38% versus 14.73%), and more physically active (percentage of participants engaged in moderate or high physical activity: 27.93% versus 27.82%). The included participants also had lower prevalence of dyslipidemia (20.86% versus 26.65%), diabetes mellitus (2.20% versus 5.04%), and self-reported cardiovascular disease or stroke (2.05% versus 3.29%).

    Participants were followed-up for a mean of 4.8 years (range: 1–14 years; interquartile range: 2–7 years). During this time, they participated in a mean of 3.5 medical visits (range: 2–19; interquartile range: 2–4). The visits were spaced at a mean interval of 23.5 months (range: 3–167 months; interquartile range: 12–26 months).

    Air Pollution Exposure Assessment

    The detailed method used to estimate PM2.5 exposure has been described in our previous studies.14,15,17,18 In brief, we used a satellite-based spatiotemporal model with a high resolution of 1 km2 to estimate the PM2.5 exposure at each participant’s address. The spatiotemporal model was developed based on aerosol optical depth data derived from the spectral data from the 2 Moderate Resolution Imaging Spectroradiometer instruments aboard the US National Aeronautics and Space Administration Terra and Aqua satellites. The model combined the satellite aerosol optical depth data and meteorologic data (ie, visibility and relative humidity) to estimate ground-level PM2.5 concentrations. The model was then applied to estimate long-term PM2.5 concentrations over the period of 2000 to 2014. We validated the model using ground-measured PM2.5 data from more than 70 monitoring stations in Taiwan and obtained correlation coefficients of 0.72 to 0.83 between the monitored and modeled annual average PM2.5 values.

    We collected each participant’s mailing address during each medical visit to enable postal delivery of the medical reports. Thus, the changes of addresses for each participant in this study were recorded and were taken into account in the exposure assessment and data analysis. Of the participants, 36 315 (26.9%) changed their addresses during the study. The addresses were geocoded to yield latitude and longitude data that were used to estimate address-specific annual average PM2.5 concentrations.19 We used the 2-year average concentration as an indicator of long-term exposure to PM2.5 and calculated this value based on the concentrations during the year of the medical examination and the preceding year. The ΔPM2.5 was defined as the value at a follow-up visit minus the corresponding value at the immediately preceding visit. A negative value from this calculation represented an improvement in the PM2.5 air quality.

    Outcome Ascertainment

    Incident hypertension was the health outcome for the current study. For each participant, the seated systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured in the morning using a computerized auto-mercury sphygmomanometer (CH-5000, Citizen, Tokyo, Japan) which were made in the right arm after a 10-minute rest. If the SBP or DBP was ≥140 or ≥90 mm Hg, respectively, a second measurement was conducted after another 10 minutes’ rest and used for the data analysis. Incident hypertension was defined as an SBP ≥140 mm Hg or a DBP ≥90 mm Hg. The end point was the first occurrence of hypertension or the last visit if hypertension did not occur.

    Covariates

    Information on a wide range of potential confounders/modifiers was also collected. Details of the health examination and quality control were described previously and in Technical Reports by the MJ Health Research Foundation.19–21 A standard paper-based self-administered questionnaire was used to collect information on the participants’ demographic characteristics, lifestyle factors, and medical history. All questionnaire questions were close-end. Information was then captured and stored in computers via optical scanning. Data cleansing was conducted by train statisticians to detect, diagnose, and edit faulty data before release for research. The body heights and weights were measured using an auto-anthropometer (Nakamura KN-5000A, Tokyo, Japan) while the participants wore light indoor clothing and no shoes. The body mass index (BMI) was calculated as the weight (kg) divided by the square of the height (m2). Blood samples were collected in the morning after an overnight fast, and the plasma glucose and lipid profiles were measured using an automated chemical analyzer.

    Statistical Analysis

    Descriptive data are presented as means (standard deviations) for continuous variables and numbers (percentages) for categorical variables.

    Because ΔPM2.5 and all other covariates (except for sex) changed over the study period, we adopted the time-varying Cox regression model, which included time-invariant and variant variables, to examine the relationship between ΔPM2.5 and development of hypertension:

    Where represents the baseline hazard function, represents the time-invariant variables, and represents the time-variant variables.

    Time-in-study (ie, follow-up time) was used as the timescale in the model. In addition to treating ΔPM2.5 as a continuous variable, we categorized this variable into tertiles and used the second tertile (ie, smallest change) as the reference value for comparisons of the effects of air quality deterioration and improvement.

    Four models were developed. Model 1 did not include any adjusted variables. Model 2 was adjusted for age (years, continuous variable), sex (male or female), educational level (lower than high school, <10; high school, 10–12; college or university, 13–16; or postgraduate, >16 years), smoking habit (never, former, or current), alcohol use (seldom, <1 time/wk; occasional, 1–3 times/wk; or regular, >3 times/wk), physical activity (defined as the product of the metabolic equivalent value [MET=1 kcal/h per kg body weight] and duration of exercise [hours]22 as inactive, <3.75; low, 3.75–7.49; medium, 7.50–16.49; high, 16.50–25.49; or very high, ≥25.50 MET-h), fruit intake (seldom, <1; moderate, 1–2; or frequent, >2 servings/d), vegetable intake (seldom, <1; moderate, 1–2; or frequent, >2 servings/d), occupational exposure to dust or organic solvents in the workplace (yes or no), and season (calendar season, categorical variable). Model 3 was further adjusted for BMI (kg/m2; continuous variable), diabetes mellitus (defined as a fasting blood glucose level ≥126 mg/dL or self-reported physician-diagnosed diabetes mellitus; yes or no), dyslipidemia (defined as a total cholesterol level ≥240 mg/dL, triglyceride level ≥200 mg/dL, or high-density lipoprotein cholesterol level <40 mg/dL; yes or no), self-reported physician-diagnosed cardiovascular disease (yes or no), and self-reported physician-diagnosed cancer (yes or no). Model 4 was further adjusted for the PM2.5 concentration at baseline (continuous variable) for comparison. We set Model 3 as our main model to address concerns that including the baseline PM2.5 concentration might lead to an overadjustment. The restricted cubic spline function was used to evaluate the shape of the concentration-response relationship between the ΔPM2.5 and incident hypertension.

    Subgroup analyses were conducted to investigate whether the relationship between the ΔPM2.5 and incident hypertension was modified by age (<65 or ≥65 years), sex (male or female), BMI (<25 or ≥25 kg/m2), educational level (<13 or ≥13 years), smoking status (never or ever), alcohol drinking (seldom or occasional/regular), and diabetes mellitus (yes or no). Each potential modifier was examined in a separate model by adding a multiplicative interaction term (ie, potential modifier×ΔPM2.5 tertile category).

    To test the stability of the relationship, 5 sensitivity analyses were conducted: (1) excluding participants who used their workplace rather than their home address to eliminate the potential misclassification of exposure due to different types of addresses; (2) excluding individuals with diabetes mellitus, self-reported physician-diagnosed cardiovascular disease, or cancer at baseline to eliminate the potential effects of comorbidity such as medications affecting blood pressure; (3) using the threshold of 130/80 mmHg according to New AHA/ACC definition of hypertension22; (4) further adjusting for calendar year to eliminate the potential effects of temporal trend as suggested by Adar SD et al23 study; and (5) using annual average PM2.5 concentration as an indicator for long-term exposure to PM2.5.

    All statistical analyses were conducted using R software, version 3.3.2 (R Core Team, Vienna, Austria). A 2-sided P value <0.05 was considered statistically significant.

    Results

    The general characteristics of the study participants are presented in Table 1. A total of 134 978 participants (49.33% men) without hypertension (mean age, 37.92±11.19 years at baseline) were included in the analysis to investigate the association between ΔPM2.5 and incident hypertension. During the follow-up period, 14 356 incident hypertension cases were identified. A majority of the participants did not use alcohol, had never been smokers, and had a relatively high level of education. Table S1 further presents the information of the participants by enrolled year.

    Table 1. Characteristics of the Participants

    VariableAll Observations* (n=469 819)Baseline of Nonhypertension (n=134 978)
    Age, y40.95 (11.13)37.92 (11.19)
    Male233 140 (49.62%)66 578 (49.33%)
    Education
     High school or lower138 318 (29.44%)42 210 (31.27%)
     College or university265 975 (56.61%)75 810 (56.16%)
     Postgraduate65 526 (13.95%)16 958 (12.56%)
    Smoking status
     Never358 212 (76.24%)101 260 (75.02%)
     Former26 480 (5.64%)7060 (5.23%)
     Current85 127 (18.12%)26 658 (19.75%)
    Alcohol drinking
     <1 time/wk404 005 (85.99%)116 915 (86.62%)
     1–3 times/wk45 688 (9.72%)12 597 (9.33%)
     >3 times/wk20 126 (4.28%)5466 (4.05%)
    Physical activity intensity
     Inactive216 280 (46.03%)68 153 (50.49%)
     Low97 197 (20.69%)29 118 (21.57%)
     Moderate86 818 (18.48%)21 991 (16.29%)
     High69 524 (14.8%)15 716 (11.64%)
    Occupational exposure, solvent/dust36 943 (7.86%)11 238 (8.33%)
    Body mass index, kg/m222.81 (3.32)22.61 (3.38)
    Systolic blood pressure, mm Hg113.09 (13.50)113.36 (12.73)
    Diastolic blood pressure, mm Hg68.60 (9.50)68.05 (8.95)
    Diabetes mellitus12 156 (2.59%)2968 (2.20%)
    Self-reported cardiovascular disease or stroke10 749 (2.29%)2765 (2.05%)
    Dyslipidemia§98 251 (20.91%)28 157 (20.86%)
    2-year average PM2.5, μg/m326.63 (7.69)26.77 (7.99)

    The statistical data are shown as means (standardized deviations) for continuous variables and counts (percentages) for categorical variables.

    Data are complete for all variables.

    *Characteristics of the 469 819 observations from the 134 978 participants.

    †Characteristics of the 134 978 nonhypertensive participants at baseline.

    ‡Diabetes mellitus: fasting blood glucose ≥126 mg/dL or self-reported physician-diagnosed diabetes mellitus.

    §Dyslipidemia: total cholesterol ≥240 mg/dL, triglyceride ≥200 mg/dL, or high-density lipoprotein cholesterol <40 mg/dL.

    The spatial distribution of study participants/observations by year is presented in Figure 1. As demonstrated, the participants generally lived in the Western part of the island of Taiwan. The PM2.5 concentrations increased in 2002, 2003, and 2004 and began to decrease in 2005. The values of 2-year average concentrations of PM2.5 in Taiwan from 2001 to 2014 are shown in Table S2.

    Figure 1.

    Figure 1. Maps of the participants’ location and the trends in the 2-year average concentrations of particulate matter (PM2.5) in Taiwan from 2001 to 2014. A, is the map of the address locations (circles) of the 134 978 participants at baseline by year. B, is the map of the address locations (circles) of the 469 819 observations from the 134 978 participants by year. C, shows the trends in the 2-year average concentrations of PM2.5 in the 469 819 observations in Taiwan between 2001 and 2014.

    The effects of ΔPM2.5 on hypertension development are presented in Table 2 and Figure 2. Compared with participants whose exposure corresponded to the second tertile of ΔPM2.5, (the smallest change in PM2.5), those in the first tertile (ie, improved PM2.5 air quality) exhibited a decreased risk of developing hypertension (hazard ratio, 0.81; 95% CI, 0.78–0.85] while those in the third tertile (deteriorated PM2.5 air quality) faced in an increased risk of developing hypertension (hazard ratio, 1.16; 95%CI, 1.11–1.21). A liner concentration-response curve was observed. Every 5 µg/m3 change in the PM2.5 was associated with a 16% change in the incidence of hypertension. In other words, a 5 µg/m3 improvement in PM2.5 air quality was associated with a 16% decrease in the risk of developing hypertension (hazard ratio, 0.84; 95%CI, 0.82–0.86; Figure 2).

    Table 2. The Associations of ΔPM2.5 With Hypertension Development

    PM2.5 ExposureModel 2Model 3Model 4
    HR (95% CI)P ValueHR (95% CI)P ValueHR (95% CI)P ValueHR (95% CI)P Value
    First tertile (<−0.92)0.80 (0.78–0.83)<0.0010.82 (0.78–0.85)<0.0010.81 (0.78–0.85)<0.0010.78 (0.75–0.82)<0.001
    Second tertile (−0.92 to 0.33)RefRefRefRef
    Third tertile (>0.33)1.16 (1.11–1.21)<0.0011.14 (1.10–1.19)<0.0011.16 (1.11–1.21)<0.0011.16 (1.11–1.21)<0.001
    Trend test<0.001<0.001<0.001<0.001
    Every 5 µg/m3 decrease0.84 (0.82–0.86)<0.0010.85 (0.83–0.87)<0.0010.84 (0.82–0.86)<0.0010.81(0.80–0.83)<0.001

    Data are completed for all variables.

    Model 1: no adjustment; Model 2: adjusted for age, sex, education, smoking, alcohol drinking, leisure-time physical activity, fruit intake, vegetable intake, occupational exposure to dust and organic solvent and season; Model 3: further adjusted for body mass index, diabetes mellitus (yes or no), dyslipidemia (yes or no), self-reported physician-diagnosed cardiovascular disease (yes or no), and self-reported physician-diagnosed cancer (yes or no). Model 4: further adjusted for the baseline PM2.5 concentration.

    Figure 2.

    Figure 2. Shape of the concentration-response relationship between the change in particulate matter (PM2.5; ΔPM2.5) and incident hypertension.

    The subgroup analyses generally yielded results consistent with the above findings (Table 3). Statistically significant interactions were observed in the following analyses: age/BMI and first tertile ΔPM2.5, BMI, and third tertile ΔPM2.5. The sensitivity analyses also generally yielded similar results (Table S3).

    Table 3. Stratified Analyses of the Associations of ΔPM2.5 With Incident Hypertension by Covariates at Baseline

    CovariateCase/ParticipantsFirst TertileSecond TertileThird Tertile
    HR (95% CI)P ValueHR (95% CI)HR (95% CI)P Value
    Sex
     Male9334/66 5780.82 (0.78–0.86)<0.001Ref1.14 (1.08–1.20)<0.001
     Female5022/68 4000.81 (0.75–0.86)<0.001Ref1.21 (1.13–1.31)<0.001
    Pinteraction0.1050.203
    Age, y
     <6513 136/131 5300.81 (0.78–0.85)<0.001Ref1.14 (1.09–1.19)<0.001
     ≥ 651220/34480.72 (0.63–0.83)<0.001Ref1.25 (1.09–1.44)<0.001
    Pinteraction0.0060.855
    BMI, kg/m2
     <258224/105 3150.88 (0.83–0.93)<0.001Ref1.21 (1.15–1.29)<0.001
     ≥ 256132/29 6630.73 (0.69–0.78)<0.001Ref1.09 (1.03–1.16)0.004
    Pinteraction<0.001<0.001
    Education
     <13 y6449/42 2100.81 (0.76–0.86)<0.001Ref1.22 (1.15–1.30)<0.001
     ≥13 y7907/92 7680.81 (0.77–0.86)<0.001Ref1.12 (1.06–1.18)<0.001
    Pinteraction0.9870.077
    Smoking status
     Never10 061/101 2600.81 (0.77–0.85)<0.001Ref1.16 (1.11–1.22)<0.001
     Ever4295/33 7180.83 (0.78–0.90)<0.001Ref1.14 (1.06–1.23)<0.001
    Pinteraction0.5070.317
    Alcohol drinking
     Seldom11 563/116 9150.81 (0.77–0.85)<0.001Ref1.17 (1.12–1.23)<0.001
     Occasional or regular2793/18 0630.83 (0.76–0.91)<0.001Ref1.13 (1.03–1.25)0.010
    Pinteraction0.5740.541
    Diabetes mellitus
     No13 573/132 0100.81 (0.78–0.85)<0.001Ref1.15 (1.10–1.20)<0.001
     Yes783/29680.77 (0.65–0.92)0.003Ref1.27 (1.07–1.52)0.007
    Pinteraction0.8840.142

    Data are completed for all variables.

    Adjusted for age, sex (except in the sex-stratified analysis), education (except in the education-stratified analysis), smoking (except in the smoking-stratified analysis), alcohol consumption (except in the alcohol-stratified analysis), leisure-time physical activity, fruit intake, vegetable intake, occupational exposure to dust and organic solvents, season, body mass index, diabetes mellitus (except in the diabetes mellitus-stratified analysis), dyslipidemia (yes or no), self-reported physician-diagnosed cardiovascular disease (yes or no), and self-reported physician-diagnosed cancer (yes or no).

    Discussion

    To the best of our knowledge, this is the first large longitudinal study to investigate the relationship between dynamic changes in long-term exposure to PM2.5 (including air quality improvement and deterioration) and incident hypertension. We found that deteriorations in the ambient PM2.5 air quality are associated with a higher risk of hypertension development, whereas improvements in long-term exposure to PM2.5 are associated with a lower risk of hypertension development. The concentration-response relationship is generally linear.

    Limited information is available regarding the relationship between dynamic changes in exposure to air pollution, particularly long-term exposure and hypertension development. There is a few trials that investigated the short-term effects on blood pressure: one clinical trial in the United States suggested that short-term use of portable air filtration systems might lower systolic BP among older adults living in a typical US urban location24; another 3 trials reported that air purification decreased both SBP25–27 and DBP.25,27 One cohort study in China investigated the health effects of drastic air quality changes surrounding the 2008 Beijing Olympics and found significantly lower SBP measurements during the Olympics (ie, a period of low air pollution) than during the post-Olympics period (ie, high air pollution). However, the authors did not observe higher SBP measurements during the pre-Olympics period (ie, high air pollution), compared with the Olympics period.28,29 In contrast, another panel study by Mu et al30 observed an increase in DBP but not SBP during the Olympics.

    It might be difficult to compare our results directly with those of the above studies, which evaluated relatively short exposure periods and used blood pressure as continuous outcomes. The effects of short-term exposure on blood pressure might be reversed quickly when the exposure is removed. We used 2-year average PM2.5 or annual PM2.5 (in the sensitivity analysis) as an indicator of long-term exposure in this study. It was possible that short-term (days or weeks) fluctuations in PM2.5 may sway blood pressure. We thus used hypertension as the outcome to assess the long-term effect because it takes a while for a normal person to develop hypertension. Besides, many other factors can easily fluctuate blood pressure and might lead to unstable results. A dichotomous outcome (hypertension) based on a well-defined cutoff value is more certain and stable unless the fluctuation in blood pressure is big and across the cutoff value.

    We observed an association between decreased exposure to PM2.5 and decreased risk of hypertension development, consistent with previous studies that have shown the benefits of air quality improvements on mortality, life expectancy, lung function, and respiratory systems.3,5–8 A few studies also used modeling methods to estimate the benefits of air quality improvements, although most addressed mortality.31–34 These modeling studies were generally based on the literature-derived risk of air pollution and assumed no changes in exposure, which is not the reality. The effect magnitude and the concentration-response relationship for exposure change may be quite different. Our previous study, which was based on the same cohort and assumed no changes in PM2.5 exposure during the study period, shows that each 10 µg/m3 increment in PM2.5 was associated with an increased risk of 3% in hypertension development.9 On the contrary, the present study shows a linear relationship with an hazard ratio of 0.84 for every 5 µg/m3 change in PM2.5 (ie, every 5 µg/m3 decrease in PM2.5 was associated with a decreased risk of 16% in hypertension development). More studies are needed to directly assess the beneficial effects of air improvement on various health outcomes and facilitate better policy development.

    The biological mechanism underlying the relationship of PM2.5 exposure with blood pressure and hypertension is not fully understood. Hypothetically, PM2.5 might affect blood pressure by impairing endothelial function via oxidative stress and systemic inflammation.35,36 Our previous studies15,20 and other studies37–39 suggested that PM could elicit systemic inflammation, as indicated by pollution-related increases in C-reactive protein, and IL (interleukin)-6 levels and white blood cell and platelet counts. The downregulation of nitric oxide synthase may also contribute to this mechanism. PM exposure can inhibit the production of endogenous nitric oxide,40 and the reduced bioavailability of nitric oxide may contribute to the elevation of blood pressure.41,42 Besides, PM exposure might impair renal D1 receptor-mediated sodium excretion,43 activate hypothalamus-pituitary-adrenal axis,44 and cause imbalance in vascular homeostatic responses due to vascular endothelial dysfunction.45 However, different mechanisms may overlap and contribute to blood pressure elevations at different time points.

    This study has several important strengths. First, the longitudinal study design allowed us to examine the relationship between air pollution and incident hypertension in a dynamic and prospective manner. We assessed the effects of both air quality improvement and deterioration and thus demonstrated the beneficial effects of the former. In contrast to reality, most previous cohort studies assumed no changes in exposure to air pollution and covariates throughout the study period, even if a long period was explored. Second, our large sample size and relatively long follow-up period enabled us to detect small effect sizes and provide more precise estimates. Finally, we used a spatiotemporal model based on high resolution (1 km2) satellite data to estimate the PM2.5 exposure at each participant’s address. This technology permitted us to overcome the spatial coverage limitation that typically occurs when using data obtained only from monitoring stations. It also enabled us to determine individual-level exposure and to track the PM2.5 air pollution levels over time.

    Despite these strengths, the study also had several limitations. First, we lacked information about indoor pollutants. Although some studies have indicated a strong correlation between the indoor and outdoor PM concentrations, we could not exclude some potential influences on indoor PM concentrations, such as the characteristics of home ventilation and type of cooking fuel. However, we have included the effect of smoking, an important source of household air pollution. Second, information about other gaseous pollutants, such as NOx and ozone, was not available. Therefore, it was impossible for us to determine whether the observed effects were specifically attributable to PM2.5 or to the combined effects of the pollutants. Third, participants’ blood pressure was measured only once if the first blood pressure reading was not hypertensive. This is not strictly in accordance with the clinical guidelines which require multiple measurements. However, a second measurement was conducted if the first measurement was hypertensive. The second measurement could greatly minimize white coat effects. Fourth, we could not eliminate clustering effects of geographic areas. The study participants were residents across Taiwan. Some geographic factors, such as socioeconomic status and lifestyle patterns, might differ in different cities/areas and had potential effects on the association. Finally, the 134 978 participants included in this study were nonhypertensive. Thus, compared with the excluded participants, they were slightly younger, healthier, and more educated, and had slightly healthier behaviors. This selection should not affect the conclusion, as we investigated the association rather than prevalence estimate in this study. Moreover, a series of subgroup analyses and sensitivity analyses, which took into account these variables, yielded similar results, demonstrating the robustness of the association.

    Perspectives

    The current study provided the first evidence that improvement in PM2.5 exposure is associated with a lower risk of incident hypertension, whereas deterioration in ambient PM2.5 is associated with a higher risk of incident hypertension. The findings help advance our understanding of the health effects of PM2.5 on hypertension. Our study, therefore, demonstrates the beneficial effects of air quality improvement on hypertension and reinforces that mitigation of air pollution is an effective strategy to improve cardiovascular health.

    Acknowledgments

    We thanked the participants, and the MJ Health Research Foundation for authorizing our use of the MJ health data (Authorization code: MJHR2015002A). Any interpretations or conclusions described in this article do not represent the views of the MJ Health Research Foundation. We are grateful to the anonymous reviewers and the editor for their valuable comments.

    Footnotes

    The online-only Data Supplement is available with this article at https://www.ahajournals.org/doi/suppl/10.1161/HYPERTENSIONAHA.119.13212.

    Correspondence to Xiang Qian Lao, PhD, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, 4/F School of Public Health, Prince of Wales Hospital, Sha Tin, NT, Hong Kong SAR, China. Email

    References

    • 1. World Health Organization. Ambient (outdoor) Air Quality and Health, http://www.Who.Int/en/news-room/fact-sheets/detail/ambient-(outdoor)-air-quality-and-health. Accessed June 23, 2019.Google Scholar
    • 2. GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the global burden of disease study 2016.Lancet. 2017; 390:1345–1422. doi: 10.1016/S0140-6736(17)32366-8CrossrefMedlineGoogle Scholar
    • 3. Laden F, Schwartz J, Speizer FE, Dockery DW. Reduction in fine particulate air pollution and mortality: extended follow-up of the Harvard Six Cities study.Am J Respir Crit Care Med. 2006; 173:667–672. doi: 10.1164/rccm.200503-443OCCrossrefMedlineGoogle Scholar
    • 4. Huang J, Pan X, Guo X, Li G. Health impact of China’s Air Pollution Prevention and Control Action Plan: an analysis of national air quality monitoring and mortality data.Lancet Planet Health. 2018; 2:e313–e323. doi: 10.1016/S2542-5196(18)30141-4CrossrefMedlineGoogle Scholar
    • 5. Pope CA, Ezzati M, Dockery DW. Fine-particulate air pollution and life expectancy in the United States.N Engl J Med. 2009; 360:376–386. doi: 10.1056/NEJMsa0805646CrossrefMedlineGoogle Scholar
    • 6. Gauderman WJ, Urman R, Avol E, Berhane K, McConnell R, Rappaport E, Chang R, Lurmann F, Gilliland F. Association of improved air quality with lung development in children.N Engl J Med. 2015; 372:905–913. doi: 10.1056/NEJMoa1414123CrossrefMedlineGoogle Scholar
    • 7. Bayer-Oglesby L, Grize L, Gassner M, Takken-Sahli K, Sennhauser FH, Neu U, Schindler C, Braun-Fahrländer C. Decline of ambient air pollution levels and improved respiratory health in Swiss children.Environ Health Perspect. 2005; 113:1632–1637. doi: 10.1289/ehp.8159CrossrefMedlineGoogle Scholar
    • 8. Berhane K, Chang CC, McConnell R, Gauderman WJ, Avol E, Rapapport E, Urman R, Lurmann F, Gilliland F. Association of changes in air quality with bronchitic symptoms in children in California, 1993-2012.JAMA. 2016; 315:1491–1501. doi: 10.1001/jama.2016.3444CrossrefMedlineGoogle Scholar
    • 9. Zhang Z, Guo C, Lau AKH, Chan TC, Chuang YC, Lin C, Jiang WK, Yeoh EK, Tam T, Woo KS, Yan BP, Chang LY, Wong MCS, Lao XQ. Long-term exposure to fine particulate matter, blood pressure, and incident hypertension in Taiwanese adults.Environ Health Perspect. 2018; 126:017008. doi: 10.1289/EHP2466CrossrefMedlineGoogle Scholar
    • 10. Fuks KB, Weinmayr G, Hennig F, Tzivian L, Moebus S, Jakobs H, Memmesheimer M, Kälsch H, Andrich S, Nonnemacher M, Erbel R, Jöckel KH, Hoffmann B; Heinz Nixdorf Recall Study Investigative Group. Association of long-term exposure to local industry- and traffic-specific particulate matter with arterial blood pressure and incident hypertension.Int J Hyg Environ Health. 2016; 219:527–535. doi: 10.1016/j.ijheh.2016.05.008CrossrefMedlineGoogle Scholar
    • 11. Honda T, Pun VC, Manjourides J, Suh H. Associations of long-term fine particulate matter exposure with prevalent hypertension and increased blood pressure in older Americans.Environ Res. 2018; 164:1–8. doi: 10.1016/j.envres.2018.02.008CrossrefMedlineGoogle Scholar
    • 12. Xie X, Wang Y, Yang Y, Xu J, Zhang Y, Tang W, Guo T, Wang Q, Shen H, Zhang Y, Yan D, Peng Z, Chen Y, He Y, Ma X. Long-term effects of ambient particulate matter (with an aerodynamic diameter ≤2.5 μm) on hypertension and blood pressure and attributable risk among reproductive-age adults in china.J Am Heart Assoc. 2018; 7:e008553. doi: 10.1161/JAHA.118.008553LinkGoogle Scholar
    • 13. Yang BY, Qian Z, Howard SW, Vaughn MG, Fan SJ, Liu KK, Dong GH. Global association between ambient air pollution and blood pressure: a systematic review and meta-analysis.Environ Pollut. 2018; 235:576–588. doi: 10.1016/j.envpol.2018.01.001CrossrefMedlineGoogle Scholar
    • 14. Guo C, Zhang Z, Lau AKH, Lin CQ, Chuang YC, Chan J, Jiang WK, Tam T, Yeoh EK, Chan TC, Chang LY, Lao XQ. Effect of long-term exposure to fine particulate matter on lung function decline and risk of chronic obstructive pulmonary disease in Taiwan: a longitudinal, cohort study.Lancet Planet Health. 2018; 2:e114–e125. doi: 10.1016/S2542-5196(18)30028-7CrossrefMedlineGoogle Scholar
    • 15. Zhang Z, Chang LY, Lau AKH, Chan TC, Chieh Chuang Y, Chan J, Lin C, Kai Jiang W, Dear K, Zee BCY, Yeoh EK, Hoek G, Tam T, Qian Lao X. Satellite-based estimates of long-term exposure to fine particulate matter are associated with C-reactive protein in 30 034 Taiwanese adults.Int J Epidemiol. 2017; 46:1126–1136. doi: 10.1093/ije/dyx069CrossrefMedlineGoogle Scholar
    • 16. Chan TC, Zhang Z, Lin BC, Lin C, Deng HB, Chuang YC, Chan JWM, Jiang WK, Tam T, Chang LY, Hoek G, Lau AKH, Lao XQ. Long-term exposure to ambient fine particulate matter and chronic kidney disease: a cohort study.Environ Health Perspect. 2018; 126:107002. doi: 10.1289/EHP3304CrossrefMedlineGoogle Scholar
    • 17. Lin C, Li Y, Yuan Z, Lau AKH, Li C, Fung JCH. Using satellite remote sensing data to estimate the high-resolution distribution of ground-level pm2.5.Remote Sens Environ. 2015; 156:117–128.CrossrefGoogle Scholar
    • 18. Lin C, Li Y, Lau AKH, Deng X, Tse TKT, Fung JCH, Li C, Li Z, Lu X, Zhang X, Yu Q. Estimation of long-term population exposure to pm2.5 for dense urban areas using 1-km modis data.Remote Sens Environ. 2016; 179:13–22.CrossrefGoogle Scholar
    • 19. MJ Health Research Foundation. The Introduction of MJ Health Database, MJ Health Research Foundation Technical Report, MJHRF-TR-01.august, 2016. Http://www.Mjhrf.Org/file/en/report/mjhrf-tr-01mj%20health%20database.Pdf. Accessed June 23, 2019Google Scholar
    • 20. Zhang Z, Hoek G, Chang LY, et al.. Particulate matter air pollution, physical activity and systemic inflammation in Taiwanese adults.Int J Hyg Environ Health. 2018; 221:41–47. doi: 10.1016/j.ijheh.2017.10.001CrossrefMedlineGoogle Scholar
    • 21. Lao XQ, Zhang Z, Lau AKH, Chan TC, Chuang YC, Chan J, Lin C, Guo C, Jiang WK, Tam T, Hoek G, Kan H, Yeoh EK, Chang LY. Exposure to ambient fine particulate matter and semen quality in Taiwan.Occup Environ Med. 2018; 75:148–154. doi: 10.1136/oemed-2017-104529CrossrefMedlineGoogle Scholar
    • 22. Whelton PK, Carey RM, Aronow WS, et al.. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Hypertension2018; 71:e13–e115. doi: 10.1161/HYP.0000000000000065LinkGoogle Scholar
    • 23. Adar SD, Chen YH, D’Souza JC, O’Neill MS, Szpiro AA, Auchincloss AH, Park SK, Daviglus ML, Diez Roux AV, Kaufman JD. Longitudinal analysis of long-term air pollution levels and blood pressure: a cautionary tale from the Multi-Ethnic Study of Atherosclerosis.Environ Health Perspect. 2018; 126:107003. doi: 10.1289/EHP2966CrossrefMedlineGoogle Scholar
    • 24. Morishita M, Adar SD, D’Souza J, Ziemba RA, Bard RL, Spino C, Brook RD. Effect of portable air filtration systems on personal exposure to fine particulate matter and blood pressure among residents in a low-income senior facility: a randomized clinical trial.JAMA Intern Med. 2018; 178:1350–1357. doi: 10.1001/jamainternmed.2018.3308CrossrefMedlineGoogle Scholar
    • 25. Chen R, Zhao A, Chen H, Zhao Z, Cai J, Wang C, Yang C, Li H, Xu X, Ha S, Li T, Kan H. Cardiopulmonary benefits of reducing indoor particles of outdoor origin: a randomized, double-blind crossover trial of air purifiers.J Am Coll Cardiol. 2015; 65:2279–2287. doi: 10.1016/j.jacc.2015.03.553CrossrefMedlineGoogle Scholar
    • 26. Gong H, Linn WS, Sioutas C, Terrell SL, Clark KW, Anderson KR, Terrell LL. Controlled exposures of healthy and asthmatic volunteers to concentrated ambient fine particles in Los Angeles.Inhal Toxicol. 2003; 15:305–325. doi: 10.1080/08958370304455CrossrefMedlineGoogle Scholar
    • 27. Brook RD, Bard RL, Morishita M, et al.. Hemodynamic, autonomic, and vascular effects of exposure to coarse particulate matter air pollution from a rural location.Environ Health Perspect. 2014; 122:624–630. doi: 10.1289/ehp.1306595CrossrefMedlineGoogle Scholar
    • 28. Zhang J, Zhu T, Kipen H, Wang G, Huang W, Rich D, Zhu P, Wang Y, Lu SE, Ohman-Strickland P, Diehl S, Hu M, Tong J, Gong J, Thomas D; HEI Health Review Committee. Cardiorespiratory biomarker responses in healthy young adults to drastic air quality changes surrounding the 2008 Beijing olympics.Res Rep Health Eff Inst. 2013; 174:5–174.Google Scholar
    • 29. Rich DQ, Kipen HM, Huang W, et al.. Association between changes in air pollution levels during the Beijing Olympics and biomarkers of inflammation and thrombosis in healthy young adults.JAMA. 2012; 307:2068–2078. doi: 10.1001/jama.2012.3488CrossrefMedlineGoogle Scholar
    • 30. Mu L, Deng F, Tian L, Li Y, Swanson M, Ying J, Browne RW, Rittenhouse-Olson K, Zhang JJ, Zhang ZF, Bonner MR. Peak expiratory flow, breath rate and blood pressure in adults with changes in particulate matter air pollution during the Beijing Olympics: a panel study.Environ Res. 2014; 133:4–11. doi: 10.1016/j.envres.2014.05.006CrossrefMedlineGoogle Scholar
    • 31. Huang C, Moran AE, Coxson PG, Yang X, Liu F, Cao J, Chen K, Wang M, He J, Goldman L, Zhao D, Kinney PL, Gu D. Potential cardiovascular and total mortality benefits of air pollution control in Urban China.Circulation. 2017; 136:1575–1584. doi: 10.1161/CIRCULATIONAHA.116.026487LinkGoogle Scholar
    • 32. Boldo E, Linares C, Aragonés N, Lumbreras J, Borge R, de la Paz D, Pérez-Gómez B, Fernández-Navarro P, García-Pérez J, Pollán M, Ramis R, Moreno T, Karanasiou A, López-Abente G. Air quality modeling and mortality impact of fine particles reduction policies in Spain.Environ Res. 2014; 128:15–26. doi: 10.1016/j.envres.2013.10.009CrossrefMedlineGoogle Scholar
    • 33. Williams ML, Lott MC, Kitwiroon N, Dajnak D, Walton H, Holland M, Pye S, Fecht D, Toledano MB, Beevers SD. The Lancet Countdown on health benefits from the UK Climate Change Act: a modelling study for Great Britain.Lancet Planet Health. 2018; 2:e202–e213. doi: 10.1016/S2542-5196(18)30067-6CrossrefMedlineGoogle Scholar
    • 34. Guo X, Zhao L, Chen D, Jia Y, Zhao N, Liu W, Cheng S. Air quality improvement and health benefit of PM2.5 reduction from the coal cap policy in the Beijing-Tianjin-Hebei (BTH) region, China.Environ Sci Pollut Res Int. 2018; 25:32709–32720. doi: 10.1007/s11356-018-3014-yCrossrefMedlineGoogle Scholar
    • 35. Brook RD, Urch B, Dvonch JT, et al.. Insights into the mechanisms and mediators of the effects of air pollution exposure on blood pressure and vascular function in healthy humans.Hypertension. 2009; 54:659–667. doi: 10.1161/HYPERTENSIONAHA.109.130237LinkGoogle Scholar
    • 36. Heagerty AM, Heerkens EH, Izzard AS. Small artery structure and function in hypertension.J Cell Mol Med. 2010; 14:1037–1043. doi: 10.1111/j.1582-4934.2010.01080.xMedlineGoogle Scholar
    • 37. Rückerl R, Hampel R, Breitner S, et al.. Associations between ambient air pollution and blood markers of inflammation and coagulation/fibrinolysis in susceptible populations.Environ Int. 2014; 70:32–49. doi: 10.1016/j.envint.2014.05.013CrossrefMedlineGoogle Scholar
    • 38. Green R, Broadwin R, Malig B, et al.. Long- and short-term exposure to air pollution and inflammatory/hemostatic markers in midlife women.Epidemiology. 2016; 27:211–220. doi: 10.1097/EDE.0000000000000421MedlineGoogle Scholar
    • 39. Viehmann A, Hertel S, Fuks K, Eisele L, Moebus S, Möhlenkamp S, Nonnemacher M, Jakobs H, Erbel R, Jöckel KH, Hoffmann B; Heinz Nixdorf Recall Investigator Group. Long-term residential exposure to urban air pollution, and repeated measures of systemic blood markers of inflammation and coagulation.Occup Environ Med. 2015; 72:656–663. doi: 10.1136/oemed-2014-102800CrossrefMedlineGoogle Scholar
    • 40. Bhatnagar A. Environmental cardiology: studying mechanistic links between pollution and heart disease.Circ Res. 2006; 99:692–705. doi: 10.1161/01.RES.0000243586.99701.cfLinkGoogle Scholar
    • 41. Haynes WG, Noon JP, Walker BR, Webb DJ. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans.J Hypertens. 1993; 11:1375–1380.CrossrefMedlineGoogle Scholar
    • 42. Sander M, Chavoshan B, Victor RG. A large blood pressure-raising effect of nitric oxide synthase inhibition in humans.Hypertension. 1999; 33:937–942.CrossrefMedlineGoogle Scholar
    • 43. Lu X, Ye Z, Zheng S, Ren H, Zeng J, Wang X, Jose PA, Chen K, Zeng C. Long-term exposure of fine particulate matter causes hypertension by impaired renal d1 receptor-mediated sodium excretion via upregulation of g-protein-coupled receptor kinase type 4 expression in sprague-dawley rats.J Am Heart Assoc. 2018; 7:e007185. doi: 10.1161/JAHA.117.007185LinkGoogle Scholar
    • 44. Kodavanti UP. Stretching the stress boundary: linking air pollution health effects to a neurohormonal stress response.Biochim Biophys Acta. 2016; 1860:2880–2890. doi: 10.1016/j.bbagen.2016.05.010CrossrefMedlineGoogle Scholar
    • 45. Brook RD, Rajagopalan S. Particulate matter, air pollution, and blood pressure.J Am Soc Hypertens. 2009; 3:332–350. doi: 10.1016/j.jash.2009.08.005CrossrefMedlineGoogle Scholar

    Novelty and Significance

    What Is New?

    • This is the first study to evaluate the association between air quality improvement in particulate matter (PM2.5) and incident hypertension.

    What Is Relevant?

    • More than 90% of the global population resides in areas where the air quality does not reach the standards recommended by the World Health Organization.

    • Many countries dedicated in mitigation of air pollution in the past several decades.

    • Long-term exposure to PM2.5 is associated with an increased risk of hypertension development.

    Summary

    • PM2.5 concentrations increased in 2002, 2003, and 2004, but began to decrease in 2005 in Taiwan.

    • Every 5 µg/m3 decrease in long-term exposure to PM2.5 (ie, a ΔPM2.5 of −5 µg/m3) is associated with a decrease of 16% in the risk of hypertension development (hazard ratio, 0.84; 95% CI, 0.82–0.86).